Infusion medication error reduction by two-person verification: a quality improvement initiative. | AHRQ Patient Safety Network

Infusion medication error reduction by two-person verification: a quality improvement initiative. | AHRQ Patient Safety Network

• Commentary
 
• Published December 2016

Infusion medication error reduction by two-person verification: a quality improvement initiative.

Subramanyam R, Mahmoud M, Buck D, Varughese A. Pediatrics. 2016;138:e20154413.

Infusion pump programming is vulnerable to human error. This commentary describes how an improvement initiative tested a two-person verification strategy. Project leaders employed educational and feedback strategies along with plan-do-study-act cycles. The initiative resulted in reduced errors in pump programming and improvements in safety culture.

PubMed citationAvailable at

Related Resources

PRESS RELEASE/ANNOUNCEMENT

Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication—important safety precautions.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 11, 2017.

JOURNAL ARTICLE › COMMENTARY

Changing smart pump vendors: lessons learned.

Arthur KJ, Catlin AC, Quebe A, Washington A. Hosp Pharm. 2016;51:782-789.

WEB RESOURCE › MULTI-USE WEBSITE

Interference between CT and Electronic Medical Devices.

Rockville, MD: Center for Devices and Radiological Health, US Food and Drug Administration. April 12, 2016.

JOURNAL ARTICLE › STUDY

The frequency of intravenous medication administration errors related to smart infusion pumps: a multihospital observational study.

Schnock KO, Dykes PC, Albert J, et al. BMJ Qual Saf. 2017;26:131-140.

NEWSPAPER/MAGAZINE ARTICLE

Managing hospitalized patients with ambulatory pumps: findings from an ISMP survey—Part 1.

ISMP Medication Safety Alert! Acute Care Edition. November 19, 2015;20:1-5.

View More